Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of COVID-19 Vaccines—An Update
Eshani Sharma, Sraddha Revinipati, Saisha Bhandari, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 112-112
Open Access | Times Cited: 15

Showing 15 citing articles:

Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk
Dimitrios Paraskevis, Maria Gkova, Kassiani Μellou, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 12, pp. 1667-1674
Open Access | Times Cited: 26
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
The Role of Conspiracy Theories, Perceived Risk, and Trust in Science on COVID-19 Vaccination Decisiveness: Evidence from Cyprus
Marilena Mousoulidou, Andri Christodoulou, Michailina Siakalli, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 2898-2898
Open Access | Times Cited: 16
The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data
Vasileios Petrakis, Petros I. Rafailidis, Grigorios Trypsianis, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 976-976
Open Access | Times Cited: 14
Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants
Haihai Jiang, Yanru Zhou, Xiaofang Zou, et al.
Biochemistry (2023) Vol. 62, Iss. 13, pp. 2055-2064
Open Access | Times Cited: 13
COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India
Nandini Sharma, Saurav Basu, H. B. Lalwani, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1177-1177
Open Access | Times Cited: 12
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients
Andrea Haddad, Ray Hachem, Mohamed Ben Moussa, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1055-1055
Open Access | Times Cited: 2
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 community, highly vaccinated patients with high risk for severe disease: Evidence that both antivirals reduce the risk for disease progression and death
Dimitrios Paraskevis, Mary Gkova, Kassiani Μellou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Effectiveness of Nutritional Supplements for Attenuating the Side Effects of SARS-CoV-2 Vaccines
Paola Gualtieri, Domenico Trombetta, Antonella Smeriglio, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1807-1807
Open Access | Times Cited: 4
Health and Well-Being through COVID-19 Vaccination: Physical, Oral, and Psychological Effects
Kelvin I. Afrashtehfar, Carlos A. Jurado, Salem Abu-Fanas, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3117-3117
Open Access | Times Cited: 3
COVID-19: Where We Are and Where We Are Going
Ludovico Abenavoli, Ivan Gentile
Diseases (2023) Vol. 11, Iss. 1, pp. 40-40
Open Access | Times Cited: 2
Impact of COVID-19 on cancer services and patients’ outcomes: a retrospective single-center study
Baijaeek Sain, Arnab Gupta, Aruni Ghose, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 9, pp. 310-310
Open Access | Times Cited: 2
Vaccination and Therapeutics
Walid Shaban Abdella, Ahmed Nabil Selim, Sheeren Diab, et al.
Advances in experimental medicine and biology (2024), pp. 165-184
Closed Access
Rare Case of Thygeson Superficial Punctate Keratitis After COVID-19 Vaccination
Kelly Ann Hutchinson, Daniel Peretz, Mahshad Darvish-Zargar, et al.
Cornea (2023) Vol. 42, Iss. 10, pp. 1306-1308
Closed Access | Times Cited: 1
COVID-19 Associated Mucormycosis and Cytomegalovirus Infection – A Case Report
Misha Aftab Khan, Fatima Zaina, Syed Shahrukh Parvez, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top